Sunshine Biopharma, Inc.
SBFM
$1.05
$0.021.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.98M | -5.99M | -6.31M | -5.03M | -5.13M |
| Total Depreciation and Amortization | 332.10K | 298.90K | 267.30K | 245.70K | 223.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.76M | 1.62M | 1.06M | 0.00 | 12.00K |
| Change in Net Operating Assets | -1.45M | -3.04M | -2.77M | -6.27M | -7.63M |
| Cash from Operations | -5.33M | -7.12M | -7.75M | -11.05M | -12.52M |
| Capital Expenditure | -174.50K | -278.10K | -787.10K | -1.60M | -1.66M |
| Sale of Property, Plant, and Equipment | 0.00 | 10.30K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -661.80K | -616.00K | -649.10K | 115.00K | -322.30K |
| Cash from Investing | -836.30K | -883.90K | -1.44M | -1.49M | -1.98M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -100.00 | -100.00 | -17.40K | 12.40K | 0.00 |
| Issuance of Common Stock | 4.75M | 5.64M | 7.54M | 3.87M | 12.08M |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | 0.00 | -3.14M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.75M | 5.64M | 7.52M | 3.88M | 8.94M |
| Foreign Exchange rate Adjustments | 855.80K | -538.10K | 462.50K | -651.10K | -1.04M |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -563.20K | -2.90M | -1.20M | -9.31M | -6.61M |